Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Andreas Beringer"'
Autor:
C. Benedikt Westphalen, Tobias Kukiolka, Benjamin Garlipp, Lars Hahn, Martin Fuchs, Peter Malfertheiner, Marcel Reiser, Fabian Kütting, Volker Heinemann, Andreas Beringer, Dirk T. Waldschmidt
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Gemcitabine/erlotinib treatment offers limited benefit in unselected patients with pancreatic ductal adenocarcinoma (PDAC). Development of skin rash has been associated with favorable outcomes in patients treated with gemcitabine/
Externí odkaz:
https://doaj.org/article/0484dbc7c1e94e40ba3604fe80c2ce56
Autor:
Holger Moch, Marlene Thomas, Andreas Beringer, Ethan Sokol, Alwin Krämer, Jeffrey S. Ross, Ferran Losa, Giulia Baciarello, Julia A. Elvin, Dexter X. Jin, Linda Mileshkin, Nhu Ngo
Publikováno v:
The Oncologist
Background Carcinoma of unknown primary origin (CUP) accounts for 2%–5% of newly diagnosed advanced malignancies, with chemotherapy as the standard of care. CUPISCO (NCT03498521) is an ongoing randomized trial using comprehensive genomic profiling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a38f83a4848676e9d8a5048d7c48d41
http://europepmc.org/articles/PMC7930409
http://europepmc.org/articles/PMC7930409
Autor:
M. Schulze, Dirk Waldschmidt, Hans Werner Tessen, Volker Heinemann, C. Benedikt Westphalen, Matthias Groschek, Andreas Beringer, Norbert Marschner, Heinz-Gert Hoeffkes
Publikováno v:
Zeitschrift für Gastroenterologie. 58:332-340
ZusammenfasungVon allen Krebserkrankungen hat das metastasierte Pankreaskarzinom die schlechteste Prognose. Mit nab-Paclitaxel/Gemcitabin, FOLFIRINOX und Gemcitabin/Erlotinib gibt es mehrere Therapieoptionen, die das Gesamtüberleben der Patienten ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ed56e6c76d37dbff42b617caf2c208b
https://doi.org/10.1055/a-1071-8177
https://doi.org/10.1055/a-1071-8177
Autor:
Linda, Mileshkin, Tilmann, Bochtler, Gemma, Gatta, Razelle, Kurzrock, Andreas, Beringer, Mathis, Müller-Ohldach, Andy, Surinach, Camille, Perret, Marlene, Thomas, Adam, Gondos, Alwin, Krämer
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2905
Knowledge of contemporary patterns of cancer-of-unknown-primary-origin (CUP) diagnostic work-up, treatment, and outcomes in routine healthcare is limited. Thus, we examined data from elderly patients diagnosed with CUP in real-world US clinical pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eda66cd57990a256d0a5e4d54607472d
https://doi.org/10.3390/cancers14122905
https://doi.org/10.3390/cancers14122905
Autor:
Sophie Golding, Holger Moch, Christoph B. Westphalen, Ethan Sokol, Andreas Beringer, Ferran Losa, E. Hoglander, Chantal Pauli, N. Chalabi, Alwin Krämer, G. Duran-Pacheco, Jeffrey S. Ross, Linda Mileshkin, A. Karapetyan, Natalie Cook, Tilmann Bochtler, Richard W. Tothill
Publikováno v:
Annals of Oncology. 32:S1227-S1228
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85ab00733ccfec40005762853cf0670c
https://doi.org/10.1016/j.annonc.2021.08.258
https://doi.org/10.1016/j.annonc.2021.08.258
Autor:
Jeremy Scarato, George Pentheroudakis, Linda Mileshkin, Marlene Thomas, Mathis Mueller-Ohldach, Alwin Krämer, Giulia Baciarello, Chantal Pauli, Holger Moch, Jeffrey S. Ross, George Zarkavelis, Andreas Beringer, Ferran Losa, Suayib Yalcin, Tilmann Bochtler, Mustafa Ozguroglu
Publikováno v:
The Oncologist
Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing molecularly guided therapy versus platinum‐based chemotherapy in patients newly diagnosed with “unfavorable” cancer of unknown primary (CUP). Materials and Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0a78a3a2c80ec6c871198e270691b0
https://hdl.handle.net/20.500.12831/6561
https://hdl.handle.net/20.500.12831/6561
Autor:
Martin Fuchs, Dirk Waldschmidt, Andreas Beringer, Fabian Kütting, Lars Hahn, Tobias Kukiolka, C. Benedikt Westphalen, Volker Heinemann, Benjamin Garlipp, Peter Malfertheiner, M. Reiser
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Background Gemcitabine/erlotinib treatment offers limited benefit in unselected patients with pancreatic ductal adenocarcinoma (PDAC). Development of skin rash has been associated with favorable outcomes in patients treated with gemcitabine/erlotinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf6fe9205dbef3cd60a46eecbcb80a4a
https://doi.org/10.1186/s12885-020-6636-7
https://doi.org/10.1186/s12885-020-6636-7
Autor:
C Benedikt, Westphalen, Volker, Heinemann, Hans Werner, Tessen, Matthias, Groschek, Heinz-Gert, Hoeffkes, Norbert, Marschner, Mathias, Schulze, Andreas, Beringer, Dirk, Waldschmidt
Publikováno v:
Zeitschrift fur Gastroenterologie. 58(4)
Metastatic pancreatic cancer has the worst prognosis of all cancers. With nab-Paclitaxel/gemcitabine, FOLFIRINOX, and gemcitabine/erlotinib, several treatment options are available which improve the patient's overall survival. Especially for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61d0433e61e8be471c058f41c34758f5
https://pubmed.ncbi.nlm.nih.gov/32052394
https://pubmed.ncbi.nlm.nih.gov/32052394
Autor:
Lena J. Daumann, Jörg Stierstorfer, Andreas Beringer, Maximilian H. H. Wurzenberger, Norbert Szimhardt
Publikováno v:
Journal of Materials Chemistry A. 5:23753-23765
The synthesis and characterization of 1-methyl-5H-tetrazole (1, MTZ) from 1,5H-tetrazole and methyl iodide is achieved. This neutral ligand was evaluated for its use in energetic transition metal complexes. The formation of complexes is a valuable co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ecebefe0eccc9452efb6152b67ce472
https://doi.org/10.1039/c7ta07780g
https://doi.org/10.1039/c7ta07780g
Autor:
Ramona Plothe, Britta Glowacki, Angela Metz, Thomas Rösener, Michael Scheckenbach, Sonja Herres-Pawlis, Andreas Koszalkowski, Andreas Beringer, Janna Michaelis de Vasconcellos, Roxana Haase, Ulrich Flörke, Alexander Hoffmann
Publikováno v:
European Journal of Inorganic Chemistry. 2016:4974-4987
The synthesis of the new hybrid guanidine ligands DMEGdmap, DMEGdeae, TMGdmab, DMEGdmab, TMGdeab and DMEGdeab is reported. These ligands were combined with zinc chloride, and the six obtained new complexes were structurally characterised by X-ray cry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4201de46ee88ef524c55167882fb054a
https://doi.org/10.1002/ejic.201600870
https://doi.org/10.1002/ejic.201600870